Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Laskey, Sarah B ^a   Pohlmeyer, Christopher W ^a   Bruner, Katherine M ^a   Siliciano, Robert F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; CLONAL VARIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IDENTITY; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; VIRUS GENOME; CELL LINE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROCEDURES;

CELL LINE; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; POLYMERASE CHAIN REACTION;

EID: 84984827977     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005689     Document Type: Article

References (28)

1. Chun T-W, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387: 183–188. doi: 10.1038/387183a09144289
2. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278: 1295–300. 9360927
3. Wong JK, Hezareh M, Günthard HF, Havlir D V, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278: 1291–5. 9360926
4. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5: 512–7. doi: 10.1038/839410229227
5. Ruelas DS, Greene WC, An Integrated Overview of HIV-1 Latency. Cell. 2013;155: 519–529. doi: 10.1016/j.cell.2013.09.04424243012
6. Bruner KM, Hosmane NN, Siliciano RF, Towards an HIV-1 cure: measuring the latent reservoir. Trends Microbiol. 2015;23: 192–203. doi: 10.1016/j.tim.2015.01.01325747663
7. Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science (80-). 2014;345: 179–183. doi: 10.1126/science.125419424968937
8. Wagner TA, McLaughlin S, Garg K, Cheung CYK, Larsen BB, Styrchak S, et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science. 2014;345: 570–3. doi: 10.1126/science.125630425011556
9. Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, et al. HIV-1 integration landscape during latent and active infection. Cell. 2015;160: 420–32. doi: 10.1016/j.cell.2015.01.02025635456
10. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rübsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993;262: 1257–61. 8235655
11. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41: 4531–6. 14532178
12. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol. 2005;43: 406–13. doi: 10.1128/JCM.43.1.406–413.200515635002
13. Bailey JR, Sedaghat AR, Kieffer T, Brennan T, Lee PK, Wind-Rotolo M, et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol. 2006;80: 6441–57. doi: 10.1128/JVI.00591-0616775332
14. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009;206: 1273–89. doi: 10.1084/jem.2009037819487424
15. Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, et al. Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes. J Virol. 2011;85: 7523–7534. doi: 10.1128/JVI.02697-1021593162
16. Evering TH, Mehandru S, Racz P, Tenner-Racz K, Poles MA, Figueroa A, et al. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. PLoS Pathog. 2012;8: e1002506. doi: 10.1371/journal.ppat.100250622319447
17. Wagner TA, McKernan JL, Tobin NH, Tapia KA, Mullins JI, Frenkel LM, An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells. J Virol. 2013;87: 1770–8. doi: 10.1128/JVI.01985-1223175380
18. Kearney MF, Spindler J, Shao W, Yu S, Anderson EM, O’Shea A, Siliciano RF, et al. Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy. PLoS Pathog. 2014;10: e1004010. doi: 10.1371/journal.ppat.100401024651464
19. Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, et al. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol. 2005;79: 9625–34. doi: 10.1128/JVI.79.15.9625–9634.200516014925
20. Bull ME, Learn GH, McElhone S, Hitti J, Lockhart D, Holte S, et al. Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J Virol. 2009;83: 6020–8. doi: 10.1128/JVI.02664-0819339344
21. Siliciano JD, Siliciano RF, Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304: 3–15. doi: 10.1385/1-59259-907-9:00316061962
22. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105: 7552–7. doi: 10.1073/pnas.080220310518490657
23. Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, Gaschen B, et al. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog. 2009;5: e1000414. doi: 10.1371/journal.ppat.100041419424423
24. Ho Y-C, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DIS, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013;155: 540–51. doi: 10.1016/j.cell.2013.09.02024243014
25. Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol. 2004;11: 435–442. doi: 10.1038/nsmb75815098018
26. Suspène R, Rusniok C, Vartanian JP, Wain-Hobson S, Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication. Nucleic Acids Res. 2006;34: 4677–4684. doi: 10.1093/nar/gkl55516963778
27. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R, Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc Natl Acad Sci. 2011;108: 20166–20171. doi: 10.1073/pnas.111006410822135472
28. Bruner K, et al. Rapid accumulation of defective proviruses complicates HIV-1 reservoir measurements. Nat Med (in press).